Healthcare: Cann(‘t)Trust? And, What’s Behind Gilead’s Latest Mega-Deal
Industry Focus - Un pódcast de The Motley Fool
Categorías:
Marijuana stock CannTrust has revealed its been growing pot in unlicensed rooms, calling into question its future as a cannabis leader. Also, here’s why Gilead Sciences’ CEO just inked a multibillion deal with Galapagos to develop drugs together.
